| Identification | Back Directory | [Name]
7’-O-(4,4’-Dimethoxytrityloxy)morpholino uracil | [CAS]
1127343-02-5 | [Synonyms]
7'-O-DMT-morpholino uracil
7’-O-(4,4’-Dimethoxytrityloxy)morpholino uraci
7’-O-(4,4’-Dimethoxytrityloxy)morpholinouracil
7’-O-(4,4’-Dimethoxytrityloxy)morpholino uracil
2,4(1H,3H)-Pyrimidinedione, 1-[(2R,6S)-6-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-2-morpholinyl]-
1-[(2R,6S)-6-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]morpholin-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione | [Molecular Formula]
C30H31N3O6 | [MDL Number]
MFCD32215187 | [MOL File]
1127343-02-5.mol | [Molecular Weight]
529.59 |
| Hazard Information | Back Directory | [Uses]
7'-O-DMT-morpholino uracil is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. | [References]
[1] Connolly GP, et al. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol Sci. 1999 May;20(5):218-25. DOI:10.1016/s0165-6147(99)01298-5 |
|
| Company Name: |
Pharmalego
|
| Tel: |
18321033991 |
| Website: |
https://cn.pharmalego.com/ |
|